Indian Accounting Research Analyst, Trudence Capital Advisors

Nitin Mangal

Nitin is founder of Trudence Capital with more than 15 years of experience in Indian equities. He is Pioneer of Corporate Governance and Accounting Research in Indian Market and has successfully developed product for Institutional Investors named as "Analysis Beyond Consensus" during his association with Edelweiss Securities Ltd, Mumbai.  Later during the career, he has worked with Veritas Investment Research Corporation, Canada as Asia Consultant covering Indian and US equities. He has been profiled by leading financial news papers such as Wall Street Journal, Financial Times, Business Standard etc.

Indian Accounting Research Analyst

Advanced Enzyme Technologies (ADVENZY IN)

<p>A classic case of MOAT business, Advanced Enzyme Technologies Limited <a href="https://www.smartkarma.com/entities/26960" target="_blank" data-smartkarma-citation="entities:26960:1">Advanced Enzyme Technologies (ADVENZY IN)</a> (AETL) operates in the field of enzymes. AETL hit the bourses in mid-2016 and with operating margins in the range of 40-42%, it carries the tag of a lucrative investment opportunity. The company operates globally with India and US being the highest revenue contributing geographies. A New business venture in Palm Oil in Malaysia provides AETL immense opportunity for growth.</p><p>Notwithstanding this feel-good image, AETL’s public disclosures reveal certain practices that require careful attention and vetting.</p>

A classic case of MOAT business, Advanced Enzyme Technologies Limited Advanced Enzyme Technologies (ADVENZY IN) (AETL) operates in the field of enzymes. AETL hit the bourses in mid-2016 and with operating margins in the range of 40-42%, it carries the tag of a lucrative investment opportunity. The company operates globally with India and US being the highest revenue contributing geographies. A New business venture in Palm Oil in Malaysia provides AETL immense opportunity for growth.Notwithstanding this feel-good image, AETL’s public disclosures reveal certain practices that require careful attention and vetting.

Advanced Enzyme Technologies Limited: ‘Enzyme’ Encoded With Enigma